Effects of HDACi on Immunological Functions

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Histone deacetylase inhibitors (HDACi) are clinically relevant therapeutics for B cell malignancies.
• HDACi are known to modulate immune cell function, including B cells.
• Understanding HDACi effects on B cell differentiation, proliferation, and survival is crucial.

Purpose of the Study:

• To establish an in vitro method for investigating HDACi effects on naïve B cells.
• To specifically examine the impact of HDACi on class-switch recombination (CSR) in B cells.

Main Methods:

• Utilizing flow cytometry to analyze B cell populations.
• Implementing in vitro culture systems for naïve B cells.
• Treating B cells with specific HDAC inhibitors.

Main Results:

• The described method allows for the quantitative assessment of HDACi-induced changes in B cells.
• Flow cytometry enables detailed analysis of B cell responses to HDACi treatment.
• Specific effects of HDACi on CSR can be elucidated.

Conclusions:

• This protocol provides a framework for studying HDACi's influence on B cell CSR in vitro.
• The findings contribute to understanding HDACi's immunomodulatory roles.
• This method can be adapted to study other B cell functions and drug treatments.